# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-252207
Filing Date
2025-10-28
Accepted
2025-10-28 07:05:26
Documents
28
Period of Report
2025-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | alks-20251028.htm iXBRL | 8-K | 60624
2 | EX-99.1 | alks-ex99_1.htm | EX-99.1 | 591854
3 | EX-99.2 | alks-ex99_2.htm | EX-99.2 | 15998
4 | GRAPHIC | alks-ex99_2s1.jpg | GRAPHIC | 228798
5 | GRAPHIC | alks-ex99_2s2.jpg | GRAPHIC | 757061
6 | GRAPHIC | alks-ex99_2s3.jpg | GRAPHIC | 120859
7 | GRAPHIC | alks-ex99_2s4.jpg | GRAPHIC | 226588
8 | GRAPHIC | alks-ex99_2s5.jpg | GRAPHIC | 264789
9 | GRAPHIC | alks-ex99_2s6.jpg | GRAPHIC | 247305
10 | GRAPHIC | alks-ex99_2s7.jpg | GRAPHIC | 400413
11 | GRAPHIC | alks-ex99_2s8.jpg | GRAPHIC | 110041
12 | GRAPHIC | alks-ex99_2s9.jpg | GRAPHIC | 275467
13 | GRAPHIC | alks-ex99_2s10.jpg | GRAPHIC | 270582
14 | GRAPHIC | alks-ex99_2s11.jpg | GRAPHIC | 260556
15 | GRAPHIC | alks-ex99_2s12.jpg | GRAPHIC | 97373
16 | GRAPHIC | alks-ex99_2s13.jpg | GRAPHIC | 206432
17 | GRAPHIC | alks-ex99_2s14.jpg | GRAPHIC | 290823
18 | GRAPHIC | alks-ex99_2s15.jpg | GRAPHIC | 238310
19 | GRAPHIC | alks-ex99_2s16.jpg | GRAPHIC | 134333
| Complete submission text file | 0001193125-25-252207.txt |  | 6501798

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
20 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alks-20251028.xsd | EX-101.SCH | 30799
31 | EXTRACTED XBRL INSTANCE DOCUMENT | alks-20251028_htm.xml | XML | 4683

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 251421260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)